Efficacy and Safety of the Novel Selective Nicotinic Acetylcholine Receptor Partial Agonist, Varenicline, for Smoking Cessation

Archives of Internal Medicine
doi 10.1001/archinte.166.15.1571
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)